Shay Capital LLC - TRANSCODE THERAPEUTICS INC ownership

TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 14 filers reported holding TRANSCODE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Shay Capital LLC ownership history of TRANSCODE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$5,098
-49.7%
15,0600.0%0.00%
-66.7%
Q4 2022$10,135
-40.4%
15,0600.0%0.00%
-25.0%
Q3 2022$17,000
-10.5%
15,0600.0%0.00%0.0%
Q2 2022$19,000
-55.8%
15,0600.0%0.00%
-33.3%
Q1 2022$43,000
+13.2%
15,0600.0%0.01%0.0%
Q4 2021$38,000
-15.6%
15,0600.0%0.01%0.0%
Q3 2021$45,00015,0600.01%
Other shareholders
TRANSCODE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,289,000$1,418,0000.44%
Worth Venture Partners, LLC 324,157$357,0000.22%
Redmond Asset Management, LLC 90,874$100,0000.04%
ACT CAPITAL MANAGEMENT, LLC 6,500$7,0000.01%
K.J. Harrison & Partners Inc 19,987$22,0000.01%
Shay Capital LLC 15,060$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 76,549$84,0000.00%
STATE STREET CORP 21,019$23,0000.00%
BlackRock Inc. 15,334$17,0000.00%
View complete list of TRANSCODE THERAPEUTICS INC shareholders